Use of CSF biomarkers in Alzheimer’s disease clinical trials

被引：0
作者：
K. Blennow
H. Zetterberg
机构：
[1] the Sahlgrenska Academy at Göteborg University,Clinical Neurochemistry Laboratory
[2] The Sahlgrenska Academy at Göteborg University,Clinical Neurochemistry Lab
[3] Sahlgrenska University Hospital,undefined
来源：
JNHA - The Journal of Nutrition, Health and Aging | 2009年 / 13卷
关键词：
Mild Cognitive Impairment; Lewy Body Dementia; BACE1 Inhibitor; Secretase Inhibitor; Mild Cognitive Impairment Case;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 198 条
[71]  
Davidsson P.(undefined)undefined undefined undefined undefined-undefined
[72]  
Aevarsson O.(undefined)undefined undefined undefined undefined-undefined
[73]  
Vanderstichele H.(undefined)undefined undefined undefined undefined-undefined
[74]  
Vanmechelen E.(undefined)undefined undefined undefined undefined-undefined
[75]  
Blennow K.(undefined)undefined undefined undefined undefined-undefined
[76]  
Gustafson D.R.(undefined)undefined undefined undefined undefined-undefined
[77]  
Skoog I.(undefined)undefined undefined undefined undefined-undefined
[78]  
Rosengren L.(undefined)undefined undefined undefined undefined-undefined
[79]  
Zetterberg H.(undefined)undefined undefined undefined undefined-undefined
[80]  
Blennow K.(undefined)undefined undefined undefined undefined-undefined
3456789101112